Claims for Patent: 6,464,729

Summary for Patent: 6,464,729

Title:	Reconstituted mineralized cartilage tissue
Abstract:	A biological material comprising a continuous layer of cartilaginous tissue reconstituted in vitro which contains components associated with cartilage mineralization. The biological material may be cultured with a mineralizing agent to form a mineralized biological material. The mineralized biological material is characterized by having a biochemical composition and physiological organization substantially similar to the deep and contiguous calcified cartilage zones of articular cartilage found in animals in vivo. Methods for preparing the biological materials and methods of using the biological materials are described.
Inventor(s):	Kandel; Rita (Toronto, CA)
Assignee:	Mount Sinai Hospital Corporation (Toronto, CA)
Application Number:	09/068,233
Patent Claims:	1. A method for producing an isolated mineralized biological material comprising a continuous layer of mineralization comprising chondrocytes having alkaline phosphatase activity and surrounded by matrix containing type I, type II and type X collagens, sulphated proteoglycans having a large hydrodynamic size, matrix vesicles and calcium hydroxyapatite crystal deposits, comprising: (a) isolating chondrocytes from the lower 15% of animal articular cartilage tissue having an alkaline phosphatase activity of at least 2 .mu.M PNP/hr/.mu.g DNA; (b) forming a layer of the chondrocytes on a substrate wherein the substrate is bone, an engineered biomaterial or a porous tissue culture insert; (c) culturing the chondrocytes in growth media under suitable conditions so that the chondrocytes accumulate matrix and form cartilaginous tissue which contains components associated with cartilage mineralization, and (d) culturing the cartilaginous tissue in the presence of a mineralizing agent selected from the group consisting of .beta.-glycerophosphate, ATP, and phosphoethanolamine, to form the mineralized biological material. 2. A method as claimed in claim 1 wherein the chondrocytes are isolated by sequential enzyme digestion techniques. 3. A method as claimed in claim 2 wherein the chondrocytes are isolated by treatment with 0.5% protease followed by 0.04% bacterial collagenase. 4. A method as claimed in claim 1 wherein the chondrocytes are seeded on the substrate at a cell density of about 1.times.10.sup.5 to 8.times.10.sup.6 cells/cm.sup.2. 5. A method as claimed in claim 4 wherein the chondrocytes are seeded on the substrate at a cell density of about 2.times.10.sup.6 cells/cm.sup.2. 6. A method as claimed in claim 1 which further comprises transforming chondrocytes in the mineralized biological material with recombinant vectors containing an exogenous gene encoding a biologically active protein which corrects or compensates for a genetic deficiency. 7. A method as claimed in claim 1 which further comprises after step (c) culturing chondrocytes isolated from the mid and superficial zones of animal articular cartilage tissue on the cartilaginous tissue in the presence of a mineralizing agent to form a material comprising a mineralized biological material comprising a continuous layer of mineralization comprising chondrocytes surrounded by matrix containing type I, type II and type X collagens, sulphated proteoglycans having a large hydrodynamic size, matrix vesicles, and calcium hydroxyapatite crystal deposits, and a mid and superficial non-mineralized layer adjacent to and continuous with the mineralized biological material corresponding to the mid and superficial layers of articular cartilage in vivo. 8. A method as claimed in claim 1 wherein the substrate is a porous tissue culture insert coated with an attachment factor. 9. A method for producing an isolated mineralized biological material comprising a continuous layer of mineralization comprising chondrocytes having alkaline phosphatase activity and surrounded by matrix containing type I, type II and type X collagens, sulphated proteoglycans having a large hydrodynamic size, matrix vesicles and calcium hydroxyapatite crystal deposits, and a mid and a superficial non-mineralized layer adjacent to and continuous with the layer of mineralization comprising: a) isolating chondrocytes from the lower 15% of animal articular cartilage tissue having an alkaline phosphatase activity of at least 2 .mu.M PNP/hr/.mu.g DNA; b) forming a layer of the chondrocytes on a substrate wherein the substrate is bone, an engineered biomaterial or a porous tissue culture insert; c) culturing the chondrocytes in growth media under suitable conditions so that the chondrocytes accumulate matrix and form cartilaginous tissue which contains components associated with cartilage mineralization; and d) culturing chondrocytes isolated from the mid and superficial zones of animal articular cartilage tissue on the cartilaginous tissue in the presence of a mineralizing agent selected from the group consisting of .beta.-glycerophosphate, ATP, and phosphoethanolamine, to form the biological material. 10. A method as claimed in claim 9 wherein the chondrocytes are isolated by sequential enzyme digestion techniques. 11. A method as claimed in claim 9 wherein the chondrocytes are seeded on the substrate at a cell density of about 1.times.10.sup.5 to 8.times.10.sup.6 cells/cm.sup.2.

Details for Patent 6,464,729

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2015-11-06